Prothea Technologies
6 known investors
Prothea Technologies develops fluorescence imaging and optical sensing technologies for respiratory medicine and oncology applications. The company creates medical devices and diagnostic platforms focused on advancing clinical validation and regulatory approval for respiratory and cancer care.
Founders & leadership
K
KevDirector & Chief Scientific and Medical Officer
Investors · 6
Mérieux Equity Partners✓ verifiedParis · $3.2M – $86M
KorysHalle · $5.4M
Earlybird Venture Capitalreported · 2 sourcesBerlin · $540K – $12M
Old College Capitalreported · 2 sourcesEdinburgh · $190.5K
Also in the syndicate · 2
Merieux Equity PartnersleadNRW.BANK
Funding
SEC filings, press & company announcements- Undisclosed amountSeries AApr 2025
Earlybird Venture Capital (lead), Merieux Equity Partners (lead), NRW.BANK, Old College Capital
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Prothea Technologies do?
- Prothea Technologies develops fluorescence imaging and optical sensing technologies for respiratory medicine and oncology applications. The company creates medical devices and diagnostic platforms focused on advancing clinical validation and regulatory approval for respiratory and cancer care.
- Who founded Prothea Technologies?
- Prothea Technologies was founded by Kev.
- Who are Prothea Technologies's investors?
- Prothea Technologies's investors include Mérieux Equity Partners, Korys, Earlybird Venture Capital, Old College Capital.